Control group:Refer to the National Health Office Medical Letter (2020) 77 document "Diagnosis and treatment plan for the novel coronavirus disease (trial version 5)" general treatment plan.
Sponsors
Affiliated Hospital of traditional Chinese and Western Medicine Nanjing University of Chinese Medicine
Conditions
Novel Coronavirus Pneumonia (COVID-19)
Early Phase 1
Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19)
Active, not recruitingITMCTR2000003080
Start: 2020-02-26Updated: 2023-02-20
Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19)
Active, not recruitingChiCTR2000030479
Start: 2020-02-26Updated: 2020-03-09